GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Suzuken Co Ltd (TSE:9987) » Definitions » Sloan Ratio %

Suzuken Co (TSE:9987) Sloan Ratio % : 0.00% (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Suzuken Co Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Suzuken Co's Sloan Ratio for the quarter that ended in Dec. 2023 was 0.00%.

As of Dec. 2023, Suzuken Co has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Suzuken Co Sloan Ratio % Historical Data

The historical data trend for Suzuken Co's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzuken Co Sloan Ratio % Chart

Suzuken Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.13 4.75 0.62 0.30 2.57

Suzuken Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Suzuken Co's Sloan Ratio %

For the Medical Distribution subindustry, Suzuken Co's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzuken Co's Sloan Ratio % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Suzuken Co's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Suzuken Co's Sloan Ratio % falls into.



Suzuken Co Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Suzuken Co's Sloan Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Sloan Ratio=(Net Income (A: Mar. 2023 )-Cash Flow from Operations (A: Mar. 2023 )
-Cash Flow from Investing (A: Mar. 2023 ))/Total Assets (A: Mar. 2023 )
=(20345-37270
--46361)/1146097
=2.57%

Suzuken Co's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(27681-0
-0)/1304268
=2.12%

Suzuken Co's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 2184 (Mar. 2023 ) + 3342 (Jun. 2023 ) + 12542 (Sep. 2023 ) + 9613 (Dec. 2023 ) = 円27,681 Mil.
Suzuken Co's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was 0 (Mar. 2023 ) + 0 (Jun. 2023 ) + 0 (Sep. 2023 ) + 0 (Dec. 2023 ) = 円0 Mil.
Suzuken Co's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was 0 (Mar. 2023 ) + 0 (Jun. 2023 ) + 0 (Sep. 2023 ) + 0 (Dec. 2023 ) = 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Suzuken Co  (TSE:9987) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Suzuken Co has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Suzuken Co Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Suzuken Co's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzuken Co (TSE:9987) Business Description

Traded in Other Exchanges
N/A
Address
8 Higashi Kataha-machi, Higashi-ku, Nagoya, JPN, 461-8701
Suzuken Co Ltd is a Japanese drug manufacturer. It functions through four segments: Pharmaceutical Wholesale, which sells pharmaceuticals, diagnostic drugs, and medical equipment and materials; The Pharmaceutical Manufacturing, which produces pharmaceuticals and diagnostic drugs; The Insurance Pharmacy dispenses operations based on prescriptions from medical institutions and the Medical-related Service and Others segment which sells medical books, provides nursing services and manufactures physiological examination equipment.

Suzuken Co (TSE:9987) Headlines

No Headlines